2.485USD-0.20%Mkt Cap: 9.09M $P/E: —1d ago
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in …
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap9.09M $
Enterprise Value2.77M $
Revenue (TTM)718.17K $
Gross Profit400.11K $
Net Income (TTM)-46.90M $
Revenue/Share0.4420 USD
Last Price2.485 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees115
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS1897631057
Valuation
P/E (Trailing)—
P/E (Forward)-0.21
PEG—
EV/EBITDA-0.09
EV/Revenue3.86
P/S12.66
P/B0.56
EPS (TTM)-32.26
EPS (Forward)-12.00
52W Range
1.2603% of range46.50
52W High46.50 USD
52W Low1.260 USD
Profitability
Gross Margin64.28%
Oper. Margin-6309.12%
EBITDA Margin0.00%
Profit Margin-7533.62%
ROE-227.33%
ROA-189.54%
Growth
Revenue Growth190.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.14M $
CapEx (TTM)700.05K $
FCF Margin-2545.96%
FCF Yield-201.18%
Net Debt-6.20M $
Net Debt/EBITDA0.20
Balance Sheet
Debt/Equity0.06
Current Ratio2.28
Quick Ratio1.94
Book Value/Sh4.453 USD
Cash/Share2.285 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateJan 2, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.66M
Float3.49M
Insiders3.60%
Institutions9.53%
Short Interest
Short Ratio0.1d
Short % Float3.52%
Short % Out.3.41%
Shares Short125.61K
Short (prev mo.)349.39K
Technical
SMA 503.679 (-32.4%)
SMA 2005.617 (-55.8%)
Beta2.85
S&P 52W Chg20.25%
Avg Vol (30d)763.87K
Avg Vol (10d)924.23K
Technical Indicators
RSI (14)39.7
MACD-0.4237
MACD Signal-0.3833
MACD Hist.-0.0404
BB Upper3.726 USD
BB Middle2.978 USD
BB Lower2.230 USD
BB Width50.24%
ATR (14)0.6235 USD
Vol Ratio (20d)0.12x